{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T12:26:19Z","timestamp":1762431979788,"version":"3.37.3"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"National Natural Science Foundation Youth Project","award":["No.81702514"],"award-info":[{"award-number":["No.81702514"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Urol"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1007\/s00345-020-03571-8","type":"journal-article","created":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T03:02:31Z","timestamp":1612148551000},"page":"2937-2943","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Whole-body MRI-based multivariate prediction model in the assessment of bone metastasis in prostate cancer"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6152-3433","authenticated-orcid":false,"given":"Rui","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingsong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenjin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yinghao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianping","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,2,1]]},"reference":[{"issue":"6","key":"3571_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68(6):394\u2013424","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"3571_CR2","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/S1470-2045(16)00107-8","volume":"17","author":"GM Duchesne","year":"2016","unstructured":"Duchesne GM, Woo HH, Bassett JK, Bowe SJ, D\u2019Este C, Frydenberg M, King M, Ledwich L, Loblaw A, Malone S (2016) Timing of androgen-deprivation therapy in patients with prostate cancer with a rising PSA (TROG 03.06 and VCOG PR 01\u201303 [TOAD]): a randomised, multicentre, non-blinded, phase 3 trial. Lancet Oncol 17(6):727\u2013737","journal-title":"Lancet Oncol"},{"issue":"6","key":"3571_CR3","doi-asserted-by":"publisher","first-page":"S25","DOI":"10.1016\/j.urology.2008.10.005","volume":"72","author":"Z Marc","year":"2008","unstructured":"Marc Z, Zelefsky MJ, Higano CS, Carroll PR (2008) Conventional treatments of localized prostate cancer. Urology 72(6):S25\u2013S35","journal-title":"Urology"},{"issue":"22","key":"3571_CR4","doi-asserted-by":"publisher","first-page":"3281","DOI":"10.1200\/JCO.2006.09.2940","volume":"25","author":"FE Lecouvet","year":"2007","unstructured":"Lecouvet FE, Daphn\u00e9 G, Annabelle S, Fran\u00e7ois J, Jacques J, Bertrand Janne DO, Patrick T, Bruno VB, Bertrand T (2007) Magnetic resonance imaging of the axial skeleton for detecting bone metastases in patients with high-risk prostate cancer: diagnostic and cost-effectiveness and comparison with current detection strategies. J Clin Oncol 25(22):3281\u20133287","journal-title":"J Clin Oncol"},{"issue":"3","key":"3571_CR5","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.mri.2009.12.008","volume":"28","author":"G Behnaz","year":"2010","unstructured":"Behnaz G, Riwa K, Shuhei K, Hiroyuki I, Kyosan Y, Susumu K, Takayuki O (2010) Detection of bone metastases using diffusion weighted magnetic resonance imaging: comparison with (11)C-methionine PET and bone scintigraphy. J Magn Reson Imaging 28(3):372\u2013379","journal-title":"J Magn Reson Imaging"},{"issue":"12","key":"3571_CR6","doi-asserted-by":"publisher","first-page":"2973","DOI":"10.1007\/s00330-010-1879-3","volume":"20","author":"F Lecouvet","year":"2010","unstructured":"Lecouvet F, Simon M, Tombal B, Jamart J, Bcvande B (2010) Whole-body MRI (WB-MRI) versus axial skeleton MRI (AS-MRI) to detect and measure bone metastases in prostate cancer. Eur Radiol 20(12):2973\u20132982","journal-title":"Eur Radiol"},{"issue":"2","key":"3571_CR7","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1148\/radiol.2016142084","volume":"279","author":"F Lecouvet","year":"2016","unstructured":"Lecouvet F (2016) Whole-body MR imaging: musculoskeletal applications. Radiology 279(2):345\u2013365","journal-title":"Radiology"},{"issue":"1","key":"3571_CR8","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.eururo.2016.05.033","volume":"71","author":"AR Padhani","year":"2017","unstructured":"Padhani AR, Lecouvet FE, Tunariu N, Koh DM, De Keyzer F, Collins DJ, Sala E, Schlemmer HP, Petralia G, Vargas HA et al (2017) METastasis reporting and data system for prostate cancer: practical guidelines for acquisition, interpretation, and reporting of whole-body magnetic resonance imaging-based evaluations of multiorgan involvement in advanced prostate cancer. Eur Urol 71(1):81\u201392","journal-title":"Eur Urol"},{"issue":"8","key":"3571_CR9","doi-asserted-by":"publisher","first-page":"4503","DOI":"10.1007\/s00330-018-5796-1","volume":"29","author":"A Larbi","year":"2019","unstructured":"Larbi A, Omoumi P, Pasoglou V, Michoux N, Triqueneaux P, Tombal B, Cyteval C, Lecouvet FEJER (2019) Whole-body MRI to assess bone involvement in prostate cancer and multiple myeloma: comparison of the diagnostic accuracies of the T1, short tau inversion recovery (STIR), and high b-values diffusion-weighted imaging (DWI) sequences. Eur Radiol 29(8):4503\u20134513","journal-title":"Eur Radiol"},{"issue":"36","key":"3571_CR10","doi-asserted-by":"publisher","first-page":"5837","DOI":"10.1200\/JCO.2007.14.3875","volume":"25","author":"V Ramachandran","year":"2007","unstructured":"Ramachandran V, Aslam S, Gary C (2007) MRI or bone scan or both for staging of prostate cancer? J Clin Oncol 25(36):5837","journal-title":"J Clin Oncol"},{"issue":"1","key":"3571_CR11","doi-asserted-by":"publisher","first-page":"59","DOI":"10.3109\/0284186X.2015.1027411","volume":"55","author":"I Jambor","year":"2016","unstructured":"Jambor I, Kuisma A, Ramadan S, Huovinen R, Sandell M, Kajander S, Kemppainen J, Kauppila E, Auren J, Merisaari H et al (2016) Prospective evaluation of planar bone scintigraphy, SPECT, SPECT\/CT, 18F-NaF PET\/CT and whole body 1.5 T MRI, including DWI, for the detection of bone metastases in high risk breast and prostate cancer patients: SKELETA clinical trial. Acta Oncol 55(1):59\u201367","journal-title":"Acta Oncol"},{"issue":"14","key":"3571_CR12","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1093\/jnci\/djt151","volume":"105","author":"AR Zlotta","year":"2013","unstructured":"Zlotta AR, Egawa S, Pushkar D, Govorov A, Kimura T, Kido M, Takahashi H, Kuk C, Kovylina M, Aldaoud N et al (2013) Prevalence of prostate cancer on autopsy: cross-sectional study on unscreened Caucasian and Asian men. J Natl Cancer Inst 105(14):1050\u20131058","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"3571_CR13","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1016\/j.eururo.2015.11.036","volume":"69","author":"S Loeb","year":"2016","unstructured":"Loeb S, Folkvaljon Y, Robinson D, Lissbrant IF, Egevad L, Stattin P (2016) Evaluation of the 2015 gleason grade groups in a nationwide population-based cohort. Eur Urol 69(6):1135\u20131141","journal-title":"Eur Urol"},{"issue":"1","key":"3571_CR14","first-page":"1","volume":"55","author":"I Jambor","year":"2015","unstructured":"Jambor I, Kuisma A, Ramadan S, Huovinen R, Sandell M, Kajander S, Kemppainen J, Kauppila E, Auren J, Merisaari H (2015) Prospective evaluation of planar bone scintigraphy, SPECT, SPECT\/CT, 18F-NaF PET\/CT and whole body 1.5 T MRI, including DWI, for the detection of bone metastases in high risk breast and prostate cancer patients: SKELETA clinical trial. Acta Oncol 55(1):1\u20139","journal-title":"Acta Oncol"},{"issue":"2","key":"3571_CR15","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/S0022-5347(05)00388-5","volume":"175","author":"SJ Freedland","year":"2005","unstructured":"Freedland SJ, Humphreys EB, Mangold LA, Eisenberger M, Dorey FJ, Walsh PC, Partin AW (2005) Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy. J Urol 175(2):564\u2013564","journal-title":"J Urol"},{"issue":"8","key":"3571_CR16","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1007\/s11547-019-00989-y","volume":"124","author":"M Salvatori","year":"2019","unstructured":"Salvatori M, Rizzo A, Rovera G, Indovina L, Schillaci O (2019) Radiation dose in nuclear medicine: the hybrid imaging. Radiol Med 124(8):768\u2013776","journal-title":"Radiol Med"},{"issue":"2","key":"3571_CR17","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.eururo.2018.07.035","volume":"75","author":"J Mateo","year":"2019","unstructured":"Mateo J, Fizazi K, Gillessen S, Heidenreich A, Perez-Lopez R, Oyen WJG, Shore N, Smith M, Sweeney C, Tombal B et al (2019) Managing nonmetastatic castration-resistant prostate cancer. Eur Urol 75(2):285\u2013293","journal-title":"Eur Urol"},{"issue":"1","key":"3571_CR18","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.eururo.2012.02.020","volume":"62","author":"FE Lecouvet","year":"2012","unstructured":"Lecouvet FE, El Mouedden J, Collette L, Coche E, Danse E, Jamar F, Machiels JP, Vande Berg B, Omoumi P, Tombal B (2012) Can whole-body magnetic resonance imaging with diffusion-weighted imaging replace Tc 99m bone scanning and computed tomography for single-step detection of metastases in patients with high-risk prostate cancer? Eur Urol 62(1):68\u201375","journal-title":"Eur Urol"},{"issue":"1","key":"3571_CR19","doi-asserted-by":"publisher","first-page":"101","DOI":"10.5334\/jbr-btr.1209","volume":"100","author":"V Pasoglou","year":"2016","unstructured":"Pasoglou V, Michoux N, Tombal B, Lecouvet F (2016) Optimising TNM staging of patients with prostate cancer using WB-MRI. J Belg Soc Radiol 100(1):101","journal-title":"J Belg Soc Radiol"},{"issue":"8","key":"3571_CR20","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1007\/s12094-019-02257-x","volume":"22","author":"I Papageorgiou","year":"2020","unstructured":"Papageorgiou I, Dvorak J, Cosma I, Pfeil A, Teichgraeber U, Malich A (2020) Whole-body MRI: a powerful alternative to bone scan for bone marrow staging without radiation and gadolinium enhancer. Clin Transl Oncol 22(8):1321\u20131328","journal-title":"Clin Transl Oncol"},{"issue":"4","key":"3571_CR21","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1007\/s00259-009-1334-3","volume":"37","author":"V Helyar","year":"2010","unstructured":"Helyar V, Mohan HK, Barwick T, Livieratos L, Gnanasegaran G, Clarke SE, Fogelman I (2010) The added value of multislice SPECT\/CT in patients with equivocal bony metastasis from carcinoma of the prostate. Eur J Nucl Med Mol Imaging 37(4):706\u2013713","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"6","key":"3571_CR22","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1002\/jbmr.3444","volume":"33","author":"GJ Cook","year":"2018","unstructured":"Cook GJ, Goh V (2018) Functional and hybrid imaging of bone metastases. J Bone Miner Res 33(6):961\u2013972","journal-title":"J Bone Miner Res"},{"issue":"1","key":"3571_CR23","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1148\/radiol.14141242","volume":"275","author":"V Pasoglou","year":"2015","unstructured":"Pasoglou V, Michoux N, Peeters F, Larbi A, Tombal B, Selleslagh T, Omoumi P, Lecouvet F (2015) Whole-body 3D T1-weighted MR imaging in patients with prostate cancer: feasibility and evaluation in screening for metastatic disease. Radiology 275(1):155\u2013166","journal-title":"Radiology"},{"issue":"3","key":"3571_CR24","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1111\/j.1754-9485.2009.02070.x","volume":"53","author":"R Venkitaraman","year":"2010","unstructured":"Venkitaraman R, Cook GJ, Dearnaley DP, Parker CC, Khoo V, Eeles R, Huddart RA, Horwich A, Sohaib SA (2010) Whole-body magnetic resonance imaging in the detection of skeletal metastases in patients with prostate cancer. J Med Imaging Radiat Oncol 53(3):241\u2013247","journal-title":"J Med Imaging Radiat Oncol"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-020-03571-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00345-020-03571-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-020-03571-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,30]],"date-time":"2021-08-30T14:08:57Z","timestamp":1630332537000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00345-020-03571-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,1]]},"references-count":24,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["3571"],"URL":"https:\/\/doi.org\/10.1007\/s00345-020-03571-8","relation":{},"ISSN":["0724-4983","1433-8726"],"issn-type":[{"type":"print","value":"0724-4983"},{"type":"electronic","value":"1433-8726"}],"subject":[],"published":{"date-parts":[[2021,2,1]]},"assertion":[{"value":"27 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"No conflicts of interest, financial or otherwise, are declared by the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Ethics approval was obtained from the Ethics Review Board of Changhai Hospital.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all patients included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}]}}